This article is the latest in an EJCTS series entitled 'The Great Debates'. We have chosen the topic of aortic valve (AoV) surgery in children, with a focus on infants and neonates. The topic was selected due to the significant challenges that AoV problems in the young may present to the surgical team. There are many areas of active controversy, despite the vast accumulated world experience. We have tried to incorporate many of these issues in the questions posed, not claiming to be all-inclusive. The individuals invited to this debate are experts in paediatric valve surgery, with broad and successful clinical experiences on multiple continents. We hope that the facts and opinions presented in this debate will generate interest and discussion and perhaps prove useful in decision-making for future complex valve cases.
INTRODUCTION
This article is the latest in an EJCTS series entitled 'Great Debate'. We have chosen the topic of aortic valve (AoV) surgery in children, with a focus on infants and neonates. The topic was selected due to the significant challenges that AoV problems in the young may present to the surgical team. There are many areas of active controversy, despite the vast accumulated world experience. We have tried to incorporate many of these issues in the questions posed, not claiming to be all-inclusive. The individuals invited to this debate are experts in paediatric valve surgery, with broad and successful clinical experiences on multiple continents. We hope that the facts and opinions presented in this debate will generate interest and discussion and perhaps prove useful in decision-making for future complex valve cases. The opinions expressed may or may not represent those of the EJCTS Editorial Board, and we have tried to encourage a free debate.
AORTIC VALVE STENOSIS IN THE NEONATE
Tom Karl: What are the major considerations for treatment of haemodynamically important aortic valve stenosis in neonates?
Yves D'Udekem
The main question for the clinician facing a neonate with severe aortic stenosis (AS) is surgery or balloon dilation. Surgery predominantly consists of repair, as the Ross procedure in the neonate is usually reserved for salvage of failed dilation procedures or, more rarely, for failed surgery. I am not aware of any team having adopted a policy of primary Ross in neonates. The comparison of the 2 approaches has been based on the risk of hospital mortality as well as the length of time between the initial intervention and valve replacement (or other first reintervention). Best current evidence for this comparison can be extracted from a recent meta-analysis gathering data for over 2000 patients, showing that when the 2 approaches are compared, there is no difference in hospital mortality and freedom from aortic valve replacement (AVR), with close to half of the patients requiring replacement within 15 years [1] . Patients undergoing surgery have fewer reinterventions, but this difference may not seem to be a valid argument in favour of surgery, due to the lesser invasiveness of catheterization procedures (Fig. 1) .
Critical AS should have an extremely low mortality. If there is any impact on mortality, the procedure offering the best chance of survival should of course be employed. However, if an equivalent early mortality can be achieved with both approaches (interventional and surgical), which one should be favoured?
For the vast majority of patients, AoV disease diagnosed at an early age requires a lifetime commitment on the part of the treating team. From this perspective, arguments advanced by partisans of balloon aortic valvuloplasty (BAV; i.e. that the procedure avoids the additional morbidity of a neonatal cardiac surgical procedure and resultant scar) are likely to carry little weight. There are today more patients treated by balloon dilatation than by surgery, but this fact is probably related more to referral patterns and biases than to an evidence-based clinical advantage. From a lifelong perspective, the approach that should be favoured should be the one that offers:
1. the possibility of never requiring a prosthetic valve replacement; 2. potential delay of the Ross procedure to as late in life as possible, or at least into adulthood, so that a better technical Ross can be performed (see below); 3. the best preservation of ventricular function.
It is impossible to discern from the existing literature the answer to the 1st question, because we do not know the late status of the valves that have been dilated in infancy [2] . With either approach, 15 years after the initial intervention, half of the patients will require AVR. We have demonstrated that patients who have extensive patch reconstruction of their valves will usually require reoperation within this time frame [3, 4] . We have also reviewed our results in Melbourne with patients who did not require the addition of a patch as part of a repair (in our experience with 457 patients, close to 50% fell into this group). Half of the infants repaired without patching did not require further intervention and were free of AS and aortic insufficiency (AI) at the last follow-up. The result in neonates with both approaches is, however, inferior to those in older children (26% vs 60% freedom from reintervention or significant AoV dysfunction at 10-year follow-up). Thus, following a policy of primary repair, it is possible that close to a third of the patients may remain free of reintervention and of significant valve disease and may have a very long-lasting result [3, 4] .
Currently, it is also almost impossible to know what proportion of patients who have undergone a balloon dilatation are free of disease at a similar follow-up interval. In the best hands, perhaps 20% remain free of reintervention, but my impression is that the majority of patients undergoing a balloon dilatation do experience residual AS or AI [2] . Nor should one completely trust the idea that an AoV can be adequately repaired at a later stage after an initial balloon dilatation [5] . The failure of the interventional procedure is usually by regurgitation. Long-standing regurgitation is responsible for thickening and retraction of the edges of the tear of the cusps where the regurgitation is located [6] . The thinnest portion of the valve, which is the area where the tear occurs at the time of BAV, becomes less pliable and usually requires patching at the time of operation. This, in turn, may compromise any chance for longevity of the repair.
The most important unanswered question is the impact on ventricular function. It has been identified that a third of the patients born with congenital AoV disease experience left ventricular diastolic dysfunction as they enter adulthood, which can have a lifelong impact on their exercise capacity and their life spans [7] . The most significant predictor of diastolic dysfunction was a previous BAV. It has been suggested that repetitive episodes of AS, which are the consequences of most early surgeries for critical AS, may be better tolerated by the left ventricle (LV) than long-standing mild-to-moderate stenosis combined with AI.
James Tweddell
For most cardiac teams in North America, BAV is the mainstay of management of the neonate with critical AS. In a landmark study, McCrindle et al. [8] from the Congenital Heart Surgeons' Society looked at the outcome for 110 neonates, comparing BAV and surgical aortic valvuloplasty (SAV). They showed equivalent results for the 2 strategies, and being less invasive, BAV was quickly adopted by most teams. Enrolment for this study began in 1994 and ended in 2000. The surgical techniques varied widely and included blunt dilatation and even open balloon dilatation, techniques rarely used today.
There are a number of more contemporary studies in which improved extracorporeal support and optimal myocardial protection have been employed. In many, a more uniform and sophisticated technical approach involving precise incision of fused commissures, thinning of leaflets and excision of nodular excrescences has been used. Such studies have shown superior reintervention-free survival for neonates and infants with AS.
The outcome of neonatal SAV could well depend on preoperative anatomy, but this has not been extensively studied. Between 70% and 75% of patients presenting in the 1st year of life with AS have a bicuspid AoV, and another 20% have a tricuspid valve. The remaining 5-10% of patients have a unicuspid valve, yet there are little data to recommend a differential approach for these 3 anatomical groups. While SAV may well achieve a superior result in those with bicuspid or tricuspid AoVs, those with a unicuspid valve may be better served with BAV. For the patient with a unicuspid valve, both SAV and BAV will be likely to result in relieving AS, but also in significant AI. However, after undergoing BAV, the patient has the added (and potentially major) challenge of recovering from cardioplegic arrest and weaning from cardiopulmonary bypass with the haemodynamic burden of significant AI.
Does the type of residual lesion actually make a difference? While it can be argued that SAV and BAV have similar reintervention rates, the latter end point, although commonly used and easy to measure, is imperfect. There are no agreed-upon (and adhered to) criteria for reintervention. In addition, SAV and BAV result in a different proportion of residual lesions. Although SAV is more likely to result in significant aortic stenosis, BAV more likely results in AI. Residual AS may be managed by BAV, whereas significant AI is more likely to require AVR. In the newborn, AoV valve repair may delay the need for AVR as compared to BAV.
In the current era, neonates and infants with a bicuspid or tricuspid valve and, importantly, AS should be considered for SAV rather than BAV as the primary treatment.
ASSOCIATED LEFT HEART LESION
Tom Karl: Treatment of AS in neonates and infants may be required in the context of associated left heart lesions, some of which would be severe even in isolation. How does this situation affect the surgical approach to the aortic valve?
Yves d'Udekem
One of the first decisions to be taken concerns the adequacy of the LV to sustain the systemic circulation. The most reliable parameter indicating the suitability of the LV is the mitral annulus diameter, which does not seem to increase when the LV is subjected to increased loading conditions. We have adopted a threshold of a mitral valve z-score of -2 as the limit, below which we would perform a univentricular repair, even though we realize that this measurement is somewhat subjective. We should take into consideration the functional opening of the mitral valve rather than just the mitral annulus diameter.
Another parameter that can preclude success of a biventricular repair is extensive endocardial fibroelastosis (EFE) of the LV. EFE may be suspected (but not confirmed) by echocardiography. In some cases, we have passed an endoscope through the AoV during cardioplegic arrest (after a gentle surgical opening of the valve) to assess the extent of EFE. While this manoeuvre may prove difficult at times, we have found that in patients with extensive EFE, the LV is usually rigid enough to allow the visualization of the entire cavity.
It has been demonstrated that in patients to whom both approaches could theoretically be offered, higher mortality will be encountered if the decision favours biventricular repair rather than single-ventricle palliation (Norwood operation or variant thereof) [9, 10] . Recovery of a borderline LV by repetitive procedures involving mitral valve repairs and resection of EFE has been attempted by the Boston Children's Hospital team, and there also may be a role for maintenance of a restrictive atrial septal communication in such cases [11, 12] . In selected cases, a hybrid Norwood approach may also be useful in the preservation of options for later biventricular repair. There is no doubt that some remarkable recovery of the LV can be observed at times, but one should be suspicious that the majority of these patients seem to develop a restrictive cardiomyopathy, as demonstrated by the elevated end-diastolic left ventricular pressures reported by the same team in patients converted to a biventricular circulation. When hesitant, we have proceeded with the repair of the aortic arch and the AoV and closely monitored the left atrial pressures. Failure of extubation or persistently elevated atrial and pulmonary arterial pressures prompts us to convert the repair to a single-ventricle palliation [13] . There seems to be a window of opportunity to act accordingly, but our feeling is that beyond 3 weeks of age, conversion of a biventricular repair to a single-ventricle circulation carries a high mortality.
James Tweddell
Critical AS in the newborn comprises a spectrum of LV hypoplasia that blends smoothly from individuals for whom biventricular repair is clearly indicated into the least severe form of hypoplastic left heart syndrome, AS with mitral valve hypoplasia. Both the Congenital Heart Surgeons' Society and the Boston Children's Hospital team have developed algorithms for determining the suitability for 2-ventricle repair in similar groups of patients [9, 14] . For the patient with intact ventricular septum and critical AS, an apex forming or nearly apex forming LV is a favourable anatomical feature. Intuitively, the dimension of the mitral valve would seem to be a strong determinant of suitability for a biventricular pathway, but in the patient with AS who remains ductal dependent, the LV will be under-filled and the true or potential dimension of the mitral valve may be unknown. Other indicators of intrinsic mitral valve abnormalities might be useful, such as the papillary muscle number and position and degree of thickening of the subvalvar tensor apparatus, although assessment of these structures can also be affected by an under-filled LV. EFE results from endocardial ischaemia from suprasystemic left ventricular endocavitary pressure and is likely to represent longstanding left ventricular outflow tract (LVOT) obstruction. EFE in the setting of a non-apex forming LV strongly favours an initially univentricular pathway. Although EFE resection to achieve a biventricular repair has been reported, the techniques, patient selection criteria and potential benefit remain controversial.
ASSOCIATED EXTRACARDIAC LESIONS
Tom Karl: How does the presence of extracardiac lesions, particularly coarctation of the aorta (Ao), affect your strategy for treatment of AS?
Yves d'Udekem
Around half of the patients with coarctation have a bicuspid AoV valve. Despite this association, only 14% of our patients with coarctation and a bicuspid AoV valve required an AoV intervention during the paediatric age period. The need for surgery for such patients usually comes later in life, after the 5th decade. Patients with aortic arch hypoplasia and/or coarctation may present with variable degrees of AS. In our experience, the great majority of patients with a hypoplastic aortic arch have some form of intracardiac shunting, a ventricular septal defect (VSD) being the most common [15] . In this setting, it may be difficult to estimate exactly the severity of AoV obstruction, and the decision to proceed with AoV surgery is based on the morphological aspects of the valve and its opening on the preoperative echocardiogram.
We favour the end-to-side repair of the coarctation and hypoplastic arch, and usually a relatively straightforward commissurotomy performed through a separate aortic incision is enough to address the valve stenosis [16] . It is been claimed that patients presenting with a small aortic annulus should prompt us at times to perform a univentricular palliation. We found the incidence of having an AoV so small that it justifies this approach to be quite low, even in patients with an interrupted aortic arch [17] . In some rare instances in which the aortic annulus is extremely small, or associated with severe dysplasia of the AoV, we have performed a Yasui procedure [Damus-type proximal aortopulmonary connection combined with LV to pulmonary artery (PA) intraventricular baffle and right ventricle (RV) to PA conduit] [18] .
James Tweddell
Coarctation of the Ao often exists with other forms of left ventricular hypoplasia, in particular a bicuspid AoV and varying degrees of left ventricular hypoplasia and mitral stenosis. Decision-making regarding 1-ventricle versus 2-ventricle pathways can be challenging. Both and Tchervenkov et al. [19] and Minich et al. [20] described patients with mild left ventricular hypoplasia and non-apex forming LVs who underwent successful coarctation repair with good results. It has been suggested that this demonstrates early 'catch-up' growth, but it is more likely to represent the underappreciated potential of the volume-deprived neonatal LV in this context. A review of the foetal circulation can help us to understand this phenomenon. In the foetus, a few minutes before birth, both ventricles share the job of pumping blood to the body. A few moments after birth, the circulation is divided into separate, serial circulations. Within this short period of time, the output of the LV across the mitral valve more than doubles, indicating that the LV and the mitral valve are prepared for an abrupt increase in work. If there is coarctation with AS and ductal-dependent systemic output, the LV remains unloaded and the full potential remains undemonstrated.
In addition to coarctation, AS is frequently seen with interrupted aortic arch. In the most common form, Type B, there is posterior malalignment of the outlet septum and a large VSD. This is a fundamentally different lesion than isolated AS. The AoV, while commonly bicuspid, is rarely thickened and not likely to have commissural fusion. In addition, the ventricle is rarely hypoplastic, and EFE is not seen. Much smaller annular dimensions of the AoV will support a biventricular circulation. For example, for a 3-kg newborn, an AoV annulus of 4.5 mm will permit a biventricular repair without significant residual AS.
An aggressive pursuit of an initial biventricular repair in the borderline LV with AS and arch hypoplasia or interruption is justified, but failure of the left atrial pressure and PA pressure to normalize within a short period, especially when combined with inability to extubate, should prompt consideration of conversion to a single-ventricle strategy. If performed within a week or 2, conversion to a single-ventricle pathway can be achieved with low additional mortality and acceptable morbidity.
SHONE COMPLEX
Tom Karl: How does the presence of the Shone complex, or related left heart obstructive morphology, affect your strategy for treatment of AS?
Yves d'Udekem
Patients with Shone syndrome have a high mortality, especially if they show clinical signs of heart failure in the 1st year of life [21, 22] . The severity of this condition and the high probability of ending up with a valve replacement often impose the need for a different strategy. We have found that a Ross procedure may be a more effective solution in this setting. Shone patients have, invariably, a small aortic root, and the enlargement requires a Ross-Konno technical strategy. When aortic surgery is necessary at an early age, a concurrent mitral valve repair is often required, and such repairs are often unsatisfactory because the valve becomes regurgitant. To minimize the effects of this mitral insufficiency, the best possible relief of the aortic obstruction is necessary. My impression is that restrictive LV cavitary size and diastolic dysfunction may also be risk factors for adverse outcome.
James Tweddell
Shone syndrome differs from other forms of LV hypoplasia in that the mitral valve is most severely impacted rather than the AoV valve. Nonetheless, such patients may have significant AS and sub-AS. Resection of sub-AS is a common operation in the Shone group, and occasionally patients will also require AoV surgery. The small annulus and hypoplastic LVOT make even simple repairs challenging, and AVR is often necessary. Realistically, AVR options in children include a pulmonary autograft (Ross procedure) or mechanical valve replacement. In children, the Ross procedure is the first choice for AVR. Because residual sub-AS will result in early autograft failure, an aortoventriculoplasty (Konno) should be used to enlarge the aortic annulus and subaortic area as necessary.
IATROGENIC AORTIC VALVE INJURY
Tom Karl: Iatrogenic lesions following interventional catheter procedures (or surgical procedures) for AS may require surgical treatment or affect the timing and technical approach. What are the important issues for such scenarios?
Yves D'Udekem
Balloon dilatation was at times responsible for massive sudden AI, requiring urgent surgery, but the complication seems to have decreased drastically even in multicentric reports [23] . In neonates, the aortic cusp tissues can be very thin and fragile. Urgent surgery to rescue a failed balloon dilatation in a neonate who suddenly develops important AI during interventional catheterization therefore often requires a Ross procedure, but operation under such conditions is associated with a high mortality [24] [25] [26] [27] . At a later stage, regurgitant valves can be repaired but usually require the addition of a leaflet patch because the regurgitation usually occurs at the site of the tear caused by the dilation, and both sides of the torn cusps are thickened and retracted.
Other trauma to the valve can usually also be repaired provided that general principles are followed. Perforation in a fragile area often necessitates addition of a patch. My preference in a neonate is glutaraldehyde-preserved autologuous pericardium, and at a later age, bovine patches can be used, provided that they are small. Repair in the area of the free edge is feasible only on the condition that coaptation of the cusps is adequate to decrease the tension on the repaired area.
James Tweddell
I agree with what has been said, but I want to point out that the AoV cusps can be injured during surgical procedures or catheter interventions other than BAV. The AoV is vulnerable to injury during surgical procedures, most commonly resection of sub-AS and VSD closure. Perforations of the valve cusps or even small free edge tears of otherwise normal valve cusps can be repaired with a durable result. In order to limit tension on the repairs, techniques for cusp perforation involve the use of patches of autologous or xenograft pericardium. Free edge tears can be repaired primarily or re-enforced with autologous or xenograft pericardium. Although successful in preserving the native valve, some degree of AI usually persists. 
Yves d'Udekem
Truncal valve surgery is commonly necessary, even if the exact indications are difficult to define. In our own series of 171 truncus patients, valve surgery was needed in 12% at the time of the initial operation. These repairs failed in half of the cases within a decade [28] . Late truncal valve surgery was only necessary in the 15% of patients who did not need a repair at the 1st operation (Fig. 2) .
The repairs performed vary according to the valvar anatomy. In neonates, cuspal tissue can be dysplastic and fragile, precluding most complex repairs. The regurgitant truncal valves at that age are often quadricuspid. Tricuspidization of the valve is the best approach for these quadricuspid valves and can be performed by 2 different techniques [29, 30] . Two small adjacent cusps can be made as one by suturing the adjoined facing free edges. This is an efficient technique to prevent cuspal prolapse. Even with very dysplastic valves, reducing the effective orifice area will improve and sometimes eliminate the regurgitation. Tricuspidization by resecting one cusp and its sinus is also a very effective technique that decreases the effective orifice area. The cusp is resected leaving some tissue on each side. The suturing of this tissue is necessary to create a new commissure. The resection of the sinus goes slightly beyond the annulus into the outflow tract. At times, a coronary branch may be coursing in this space and needs to be carefully dissected to allow the closure of the opening made in the outflow tract. Finally, the adjunction of pledgeted sub-commissural sutures should be used in some difficult situations. As has been observed in adults, these subcommissural sutures may not offer a long-lasting repair, as they may fail within months or years, but they are a very easy way to obtain an immediate improvement in a difficult situation.
Later in life, similar techniques can be used to repair truncal valves. Valve-sparing surgery may be attempted but is often precluded by the extensive dysplasia of the cusps. One should keep in mind that the majority of those undergoing a truncal valve repair will ultimately require AVR (three-quarters of our own patients eventually had a mechanical valve replacement).
James Tweddell
The semilunar valve of the patient with common arterial trunk is typically abnormal in both cusp number and morphology. Some degree of truncal valve stenosis is common, but most often it is functional, i.e. exaggerated by the increased flow across the valve preoperatively. Severe truncal valve regurgitation is found in 20-25% of patients with truncus arteriosus. For those patients with severe truncal valve regurgitation, valve repair should be part of repair of truncus arteriosus to avoid increased mortality and morbidity. The mechanisms of regurgitation involve both cusp prolapse and cusp deficiency. Repair techniques involve suspension of prolapsing cusps from the truncal wall or from adjacent cusps, which can be effective for isolated prolapse. Deficient cusps that cannot occlude the valve orifice are common with quadricuspid valves. One successful strategy is resection of one the cusps, typically the smallest, usually with the reduction of the adjacent truncal sinus, to create a tricuspid truncal valve. This strategy can achieve excellent early results that appear to be durable. Nonetheless reoperation is common. Radical repairs in this situation are challenging due to the short height of the truncal valve and the abnormal baseline anatomy. As a result, truncal valve replacement is often necessary.
AORTIC VALVE DISEASE WITH AORTIC ROOT DILATION
Tom Karl: Aortic root dilatation may complicate AoV disease, and vice versa. Marfan and Loeys-Dietz syndrome, tetralogy of Fallot and transposition late after the arterial switch operation are examples. How does this type of pathology affect the surgical approach to the AoV?
Yves d'Udekem
Aortic root dilatation is often encountered in congenital heart disease and, similarly to the adult situation, may be associated with AI. Although the ideal procedure for such cases is an AoVsparing operation, the indication for this surgery is a controversial topic. In the adult with disease of the media of the aortic root and root dilation, the decision is based on the size of the aortic root measured at the level of the sinuses and on the endsystolic and end-diastolic diameters of the LV (for patients presenting with additional AI) [31] [32] [33] . These dimensions are usually given in absolute values, which is of little use for paediatric patients. The adult literature has clearly identified that in patients with AI, an operation should be offered as soon as symptoms, impaired LV function and/or decreased exercise capacity have been identified, and the same principles should probably apply to the paediatric population.
No indexed value of maximum acceptable LV dimensions has been assessed to our satisfaction for AI in the paediatric populaton, and we are left with our subjective impression [34] . The question is similarly difficult when it comes to indications for surgery on the basis of the size of the aortic root. Patients with Marfan disease and Loeys-Dietz syndrome who require surgery in the paediatric age range often present very early (<5 years) with enormous root dilatation. We have opted to delay surgery until the ventriculoaortic junction reaches a diameter of 19-21 mm, so that the valvesparing operation performed results in the implantation of a graft that is suitable for an adult AoV and aortic root [35] [36] [37] .
Patients with truncus, tetralogy of Fallot and transposition (following an arterial switch operation) also may have important root dilation. Patients with an initially right to left shunt (as in tetralogy of Fallot) generally have a degree of root dilatation that is inversely proportional to the amount of restriction of the right ventricular outflow tract [38] . Patients after an arterial switch may have a dilated root either if they had a VSD or as a consequence of the trap-door coronary transfer technique. Patients presenting with AI after an arterial switch operation have, almost uniformly, a regurgitation that has been present since the time of the original operation [37] [38] [39] [40] . Regurgitation results in the retraction of 1 or 2 of the cusps, complicating the repair, or at times precluding it. Up to 35% of patients develop at least mild AI after the arterial switch, probably as the consequence of such enlargement of the root. It was predicted (early in the arterial switch experience) that a large proportion of patients would need reintervention. In fact, only 2% of our arterial switch patients to date have actually needed a procedure on the aortic root or the AoV.
In decision-making, one should remember that the reports of rupture or dissection are exceedingly rare in non-syndromic congenital heart patients with dilated roots [41] [42] [43] . It is very likely that the criteria applied to adults, syndromic or otherwise, do not apply in such situations [44] . The observation of an acceleration in the dilation of the root, such as a growth superior to 5 mm in diameter within a year, might be a good indication for surgery, as some patients show stable aortic root sizes while others show an increase over time.
There are several reports of AoV-sparing surgery in the paediatric population that describe disappointing results, and there may be an explanation for this [44, 45] . In Marfan disease and Loeys-Dietz syndrome, there is often a considerable discrepancy between the amount of cusp tissue and the size of the aortic root orifice. This discrepancy imposes the need for a reduction of the annulus size, proportionally more important than what is required in most adults. This in turn will require adjustment of the cusp morphology more frequently than in adults, raising the complexity of the operation.
In tetralogy of Fallot, the aortic root is embedded in the right ventricular outflow tract far more deeply than usual and that anatomical feature makes the dissection of the outside portion of the root extremely difficult. Additionally, most paediatric cardiac surgeons do not have a significant experience with less complex adult aortic root cases and are likely to be facing a more challenging learning curve than in adult cardiac surgery.
James Tweddell
Connective tissue disorders frequently require surgical intervention in children, teenagers and young adults. The most common connective tissue disorders encountered are Marfan and LoeysDietz syndromes and occasionally Ehlers-Danlos syndrome. Such patients are at risk for aortic dissection, and acute dissection has a high mortality. The most common site of initiation of dissection is the aortic root. Pre-emptive aortic root surgery theoretically will remove the most vulnerable aortic wall tissue and eliminate the risk of root dissection. Currently, indications for surgery directed at the aortic root are based on genetic diagnosis, age, absolute/relative root dimensions, rate of enlargement and family history. For paediatric patients with Marfan syndrome, an aortic root diameter >5 cm, enlargement >5 mm/year or a family history of dissection at a young age are indications for a valvesparing root reconstruction. Loeys-Dietz syndrome places patients at greater risk, and in addition to the criteria above, the threshold for absolute root dimension is decreased to 4 cm.
Valve-sparing surgical techniques to replace the aortic root can be very successful in patients with well-functioning AoVs. These techniques can be extended even to small children, although if possible, surgery should be delayed until the annulus reaches an acceptable adult size of 20 mm. Many smaller patients will have a severely dilated aortic root with an enlarged aortic annulus, and although valve-sparing root procedures will eliminate the potential for aortic annular growth, the aortic annulus is likely to be of adult size, permitting an earlier operation.
Aortic root enlargement is seen in patients with congenital heart disease, especially those with conotruncal abnormalities, and after the arterial switch operation. Although dramatic root sizes can be observed, progressive relative enlargement is less common. Patients with tetralogy of Fallot or truncus arteriosus have always had dilated aortic roots, but their risk of dissection is not as clear as that for patients with defined connective tissue disorders. Aortic dissection in adults with repaired conotruncal abnormalities is isolated to case reports in middle-aged patients with obvious and dramatic enlargement.
Individuals who have undergone an arterial switch operation, particularly those with a history of a VSD and arch obstruction, are also at risk for aortic root dilation. The neoaortic root is the repurposed pulmonary root, which, when exposed to systemic pressure, is at risk for dilation. The risk of dissection in such patients appears to be low, and the paucity of even isolated case reports confirms this. Progressive dilation, however, can have an impact on adjacent structures and may merit replacement of the ascending Ao or neoaortic root.
Progressive dilatation of the aortic root or neoaortic root results in sinotubular junction dilation and can lead to splaying of the tops of the commissures. Initially, valve leaflets appear to adapt to this geometric change, but with progressive dilation of the sinotubular junction AI will predictably evolve. Valve-sparing root reconstruction is certainly more likely to be successful prior to the development of AI. The Bentall operation may be useful when valve-sparing root replacement is not possible and may be preferred by some teams for all situations.
INFLUENCE OF PATIENT AGE ON AORTIC VALVE TREATMENT STRATEGY
Tom Karl: Since there is no definitive solution to most AoV problems in childhood, how does age of the patient influence your choice of repair and replacement strategies?
Yves d'Udekem
Age of the patient does influence the choice of the technique. During the neonatal age, the choice will be between BAV and SAV, which will then be a repair. The Ross operation is usually reserved to salvage dire situations in the neonate. The choice between the 2 approaches is therefore not based on the age alone. Beyond the neonatal period, I would recommend primary AoV repair. This strategy gives the chance to up to a third of patients to have a very long-lasting procedure. Moreover, for those who need a more complex repair and may not have a long-lasting result, I believe that a Ross procedure performed at a later age will be better in the long term, because it will provide the possibility to employ a better (supported) Ross valve implantation technique (see below) ( Fig. 3A-E) [46, 47] .
We have demonstrated that repair in childhood allows us to postpone valve replacement to adolescence for the majority of patients [3, 4] . In exceptional circumstances, a Ross can be performed using an inclusion implantation technique (the autograft being implanted as a cylinder within rather than atop the root) before adolescence, and if so, it may be the favoured option. During adolescence, the decision process changes, and all the options should be discussed with the patient and family. While a repair without any use of patch material may last for a very long time, a repair with an extensive use of patch material, such as the 3-cusp leaflet extension technique, will only last between 5 and 15 years before reoperation is required [3, 46] . Once a patient reaches an adolescent size, it becomes possible to reliably perform a Ross using an inclusion technique, imparting a more reliable longevity of the autograft [48] [49] [50] . The need for replacement of a RV to PA conduit varies greatly between individuals, but there is a good chance that this Ross will provide long-lasting relief [51, 52] . Adolescence through early adulthood is a time of life when patients are better left out of the medical system as much as possible. There is some evidence that interventions at the time of transition to adult care may prevent patients' adherence to regular follow-up. Therefore, unless I can perform a very simple repair, my threshold to perform a Ross rather than a repair is lower in adolescents and young adults than it is in younger patients. With a Ross operation, my experience suggests that it is almost guaranteed that adolescents can reach their 30s without any need for further surgeries.
In fact, the only really acceptable AVR in the paediatric and early adult age groups is the Ross procedure, because it has been shown repeatedly to provide a survival advantage over other valve substitutes [53] [54] [55] . There has been a recent trend to believe that the newer generations of bioprosthetic valve materials may provide better outcomes than in the past for adolescents and young adults. This belief is unfounded. In fact, a recent study showed that a prosthetic replacement in early adulthood reduces the patient's life span by 2 decades as compared to a Ross procedure, and there is no reason to believe that this fact would be different in adolescent patients. AVR with either a mechanical valve or a bioprosthesis should be reserved for exceptional circumstances.
James Tweddell
Aortic valve repair can be classified by the type of repair, predominant haemodynamic lesion and age of the patient. AoV repairs can be classified as simple, such as commissurotomy and cusp thinning, or radical, involving techniques of leaflet extension and suspension. Simple repairs are commonly applied to neonates and infants with predominantly AS. Multiple single-centre series show excellent early and late results with these procedures [56] [57] [58] [59] . Radical repairs are more commonly applied to children and teenagers with AI or mixed lesions with significant AI. Here, the results have generally not been satisfactory [56] . Buoyed by recent experience in adults, there has been renewed enthusiasm for radical repair techniques in children, and the idea certainly seems appealing. If successful, AoV repair would relieve the majority of the haemodynamic burden on the LV, permit growth, avoid AVR and eliminate the need for anticoagulation. In adults, successful AoV repair commonly includes techniques that are used in valve-sparing root reconstruction, including the use of prosthetic grafts to wrap the root and annulus and support the repair. In children, however, extensive external annular support will limit growth. Moreover, the typical pathology in adult valves is unquestionably far less severe than in children who are presenting at an earlier age. Even in adults, radical repairs that involve leaflet extension, a common strategy in radical repairs in children, have not resulted in a durable outcome.
Radical repairs for regurgitation require the extensive use of additional materials, either xenograft patches or glutaraldehyde preserved autologous pericardium. These materials are subject to rapid degeneration due to fibrosis, with retraction and calcification. In addition, suture lines are required to flex repeatedly, and after repair, the forces are commonly concentrated into a small regions of suture, resulting in structural failure.
Evaluating the results of repair techniques is challenging, and the most common end-point used is freedom from reoperation.
The decision to reoperate is not based exclusively on precise haemodynamic data. Rarely do reports provide the 1st onset of recurrent AI or AS (as opposed to the actual interval to reoperation) [5] . In children, radical repairs have not achieved results comparable to AVR.
The Ross procedure has been widely used in children, with excellent results, and it is the valve replacement option of choice. The German-Dutch Ross Registry shows a 10-year freedom of reoperation in excess of 90%, far superior to any reported results of AoV repair for AI in children [47] . Excellent Ross results have been achieved even in infants. One justification often raised by the proponents of AoV repair is the ability to delay AVR to an older age. In the case of the Ross procedure, there seems to be little justification for an arbitrary age cut-off.
Teenagers and young adults with a bicuspid valve and AI have been shown to have an increased risk of reintervention after the Ross procedure. This is due to root dilation, in particular around the sinotubular junction, which can cause recurrent AI. A supported Ross procedure, in which the autograft is placed within a Dacron tube graft, similar to a valve-sparing root reconstruction, prevents this problem [47] . The intermediate outcome data show no dilation and stable valve function. The supported Ross technique should be considered in any patient with an autograft annulus of adult size (>22 mm).
Finally, in children, mechanical valves provide excellent freedom from reoperation, although clearly the potential need for annular enlargement and the requirement of lifelong anticoagulation remain shortcomings. In cases in which a Ross procedure is not possible and AVR is unacceptable due to age, size or a strong desire to avoid anticoagulation, radical repair might still be a useful consideration.
THE TECHNICAL LIMITS OF AORTIC VALVE REPAIR
Tom Karl: Can you comment further on some of the techniques and limitations of AoV repair? We might focus on when a replacement strategy might be better as the primary treatment, and the problem of successive repairs, with the potential for interim degradation of left ventricular function while waiting for severity to increase enough to 'justify' reoperation.
Yves d'Udekem
The most frequently used technique of valve repair is the 3-leaflet extension of a 'tricuspidized' AoV [3, [60] [61] [62] . Most congenitally deformed AoVs are significantly dysplastic, and this technique can be applied universally in such cases with excellent immediate results. Unfortunately, the simplicity of the technique does not compensate for its short-lived advantages. Native (non-glutaraldehyde treated) autologous pericardium has been been associated with failure because of the fragility of the material [63] . Autologous pericardium treated with glutaraldehyde is therefore still the patch material of choice for paediatric AoV repair. But this tissue is devitalized and, therefore, is doomed to fail by stenosis in the growing child. It is hoped that new patch materials, such as CardioCel (Admedus, Western Australia) may be longer lasting, but results to date in leaflet repair and freehand replacement (e.g. Ozaki technique) have been limited and/or mixed [64, 65] . The repairs under discussion would last for a maximum of 10 years, so that by 15 years, all patients would need to be reoperated. It seems logical to believe that the more patch material is used in a repair, the earlier the valve failure will occur. There are yet no data on the longevity of paediatric repairs using limited amounts of patch material, such as the recreation of a new commissure. For these reasons, we have veered away from using extensive amounts of patch material, and we now perform repairs that are more similar to those employed in the adult [66, 67] . As a consequence, we are now performing many more repairs that result in a bicuspid AoV.
Some repairs may be limited to a debridement, especially in neonates. All nodular dysplasia is resected and the cusps are thinned on the LV or the aortic surface, following the valve morphology. Any fused commissure is opened. It is important not to limit the opening of the commissure to a simple incision through the fused area. In order to avoid recurrence of obstruction at this level, it is important to re-create an inter-leaflet triangle and resect all fibrous tissue in this area. If the commissure is left with insufficient support following resection, a new commissure is created with the addition of a patch material. In neonates, it is difficult to create more than 1 commissure because of the space constraint, and the valve is often left bicuspid.
Some neonatal repairs resulting in a large opening and requiring only debridement may have very long-lasting results. Those neonates left with a smaller opening of the valve will usually recover easily from surgery but will require valve replacement within the 1st year of life. One could ask whether we should not rather perform a neonatal Ross in those identified at surgery to have a potentially suboptimal result. This may be a valid question, but one should realize that the mortality of the Ross procedure in non-neonatal infants is extremely low. Just after birth, while the Ross procedure can probably be performed with a low risk in the best hands, the overall reported mortality varies between 25% and 50%, possibly because it is usually performed as a rescue procedure following other treatments [24] [25] [26] [27] .
In infants and older children, a simple debridement of the valve can also be performed in close to half of the cases. In the remaining patients, more complex interventions are necessary. Each intervention will vary with the morphology of the operated valves, but general principles can be drawn. There persists some degree of confusion in the strict definition of bicuspid and unicuspid valves, perhaps explaining the vast variation in the reported incidence of these morphological types. Most valves will have a variable fusion of 2 cusps with a raphe, but in the paediatric age, most will present additionally with some degree of commissural fusion. Such valves can be equally described as unicuspid or bicuspid but are best classified as 'unicommissural' as they have only 1 normally formed commissure. Most of these valves will need the creation of a new commissure with patches, and the issue of the raphe needs to be addressed by either superficial resection or, if larger, triangular resection and, at times, patching if there is lack of tissue. Herein, we note a clear inverse relationship between the complexity of the repair and its longevity. Therefore, in the adolescent age, the more complex the repair, the more the Ross procedure should be envisioned.
The usual mode of failure of AoV repairs is by stenosis. It is suspected that the LV recovers better from stenosis-induced hypertrophy than from dilation. There is no doubt that the left ventricular function will be better preserved with a non-leaking non-obstructive valve such as the autograft of a Ross. However, the impact of repetitive episodes of hypertrophy has not been assessed. There are to date no reports of deleterious consequences of such repetitive episodes of hypertrophy, and one may suspect, therefore, that these consequences may be more benign than the left ventricular diastolic dysfunction observed after BAV [7] .
James Tweddell
There is not much to add here. For a child of any age with a Ross option (i.e. a well-functioning pulmonary valve) and with either AI or mixed AS/AI, it would be a rare occasion in which a radical repair would be justified in preference to a Ross procedure. For a small child with AI or mixed AS/AI without a well-functioning autograft, radical valve repair may be justified in order to allow for growth so that an appropriately sized prosthesis can be placed. Residual lesions are the rule and AI can worsen unpredictably, therefore the child should be followed up closely in order to allow for timely intervention.
RHEUMATIC AORTIC VALVE DISEASE
Tom Karl: How does the presence of rheumatic valvar heart disease affect decisions regarding AoV repair versus replacement, and the actual choice of replacement?
Yves d'Udekem
Patients with rheumatic valvar heart disease are fundamentally different to those with congenital AoV disease. Typically, the patients come from low-income or otherwise depressed communities with difficult access to primary healthcare. The ongoing valvar destructive process will be limited by antibiotic prophylaxis but will be rapid without it. Clearly, a blanket policy cannot be adopted in such patients [68] .
Cusp extension has been favoured by some in rheumatic patients because of the low costs of the procedure, the absence of need for anticoagulation and the fact that it can be done at all ages [69] [70] [71] . The age, however, rarely seems to be an issue, as more than three-quarters of these patients are at least 10 years of age by the time they require surgery and are therefore candidates for all valve substitutes [68, 70, 71] . Most patients undergoing repair will require reoperation within a decade, and in areas where low-income families have to contribute to the cost of the operation, a more definitive procedure should be favoured. The access to primary healthcare should be carefully assessed. Difficulties with anticoagulation management may preclude the implantation of a mechanical valve. On the other hand, lack of compliance to medical therapy might restrict the use of cusp extension techniques because without antibiotic prophylaxis these repairs will very rapidly fail.
The Ross procedure has been shown to have a greater rate of failure in rheumatic patients, and most have advised that its use should be contraindicated in that setting [72, 73] . In a large study of 104 patients with rheumatic AoV disease undergoing a Ross procedure in Saudi Arabia, patients with concomitant mitral valve disease, a marker of the general severity of rheumatic heart disease, and with larger aortic root had the worst outcomes [74] . Remarkably, if they did not have aortic root enlargement above 28 mm or concomitant mitral valve disease, more than 80% of the patients required no reoperation for the first decade, an excellent result for such a difficult population. It, therefore, seems that a restricted portion of patients with rheumatic heart disease may be good candidate for a Ross operation, provided that they have been shown to be compliant to antibiotic prophylaxis.
James Tweddell
I support the comments of Dr. d'Udekem; however, in my opinion, rheumatic heart disease should be considered a contraindication to the Ross AVR, as the autograft valve undergoes degeneration, and has poor durability. Radical repairs requiring cusp extension also have poor outcomes. Valve replacement will likely be necessary. Bioprosthetic valves have a risk of rapid and unpredictable degeneration. A mechanical valve provides the best option with excellent durability, albeit with the need for lifelong anticoagulation.
ADVANTAGES AND DISADVANTAGES OF THE ROSS OPERATION
Tom Karl: Can you summarize what you see as the advantages and disadvantages of the Ross operation, its role in infants and the best way to do it?
Yves d'Udekem
The Ross operation opened a new avenue of treatment in paediatrics. The autograft can be used at all ages, it has the capacity to grow and does not require anticoagulation [75] . So, is it a panacea, and if so, why is it not used at all ages?
We have alluded to the fact that the Ross procedure is associated with a higher mortality in neonates, and some may reject the option at that age as an elective procedure [24] [25] [26] [27] . However, some critically ill neonates have no other option, and the Ross can be life-saving. The main issue in extending the use of the Ross procedure in children and adolescents is a technical one. Congenital AoV disease before adolescence consists, for the great majority of cases, of primary AoV stenosis. The correlate is that the aortic root of these patients is small, usually precluding the use of any implantation technique that provides external support to the autograft. Therefore, almost all Ross procedures performed in the paediatric age group are made using the free-standing root technique. We know that the majority of autografts placed as free-standing roots will dilate. We now have reports providing an estimate of the rate of failure of the autograft with time, and they are concordant with approximately 25% at 20 years. At the same time, we now have the first reports of the longevity of the autograft following the implantation technique, showing that 96% of these autografts may not need a reoperation within 15 years, provided that the root has an external support [48] .
Even though patients who undergo a Ross procedure require replacements of their RV to PA conduit and their autograft may be at risk of failing, the Ross remains a remarkable operation, with three-quarters of patients free from major issues for 20 years [76] . It should be the favoured procedure for AVR from a very early age to young adulthood, because it has been demonstrated that the Ross confers a survival advantage in these age groups [51] [52] [53] [54] [55] . The only reason why surgeons may be deterred to perform this procedure, rather than a prosthetic valve replacement, are the technical issues that may be encountered (as alluded to). These include damaging the autograft or the first septal coronary branch during harvesting, distorting the proximal suture line or the commissure during implantation, rotating the distal anastomosis, kinking the origin of the coronary arteries and so on. Some improvements to the technique have been suggested to avoid dilation of the root. These include placement of the autograft proximal suture line within the LVOT rather than above it, as mentioned.
A large proportion of Ross patients will have a bicuspid AoV and have a dilated ascending Ao and sometimes a dilated sinotubular junction. It is therefore essential for the longevity of the autograft that the surgeon readjust the size of the sinotubular junction. It has been proposed to reinforce the distal suture line with a strip of polydioxone tape [48, 52] . My own technique has been to perform a triangular resection of the ascending Ao to accomplish a plasty of this segment, following a technique described in adults [77] . There is clearly no definite answer on how to best manage this issue. If the root is large enough, especially in adolescent patients whose primary issue is AI, the autograft should be implanted within the native root. It can be implanted as a scalloped autograft in a 'subcoronary' technique [78, 79] . The autograft can also be used as a cylindrical implant within the intact native root, with 2 orifices made in the autograft sinuses in front of the native coronary ostia and suturing of these orifices within the root [80] . Alternatively, the native root may be used only as a support, with the detached coronary button sutured directly to the autograft through orifices created within the aortic wall. If the aortic root is small, then the autograft can be implanted within a Dacron graft [49, 81, 82] . (Fig. 3A-E) .
James Tweddell
The Ross operation remains the procedure of choice for paediatric patients of all ages for AoV disease that is not amenable to simple repairs. While results of the Ross procedure in neonates and small infants are not as good as those experienced in older children, this is likely to reflect the severity of the underlying heart disease.
Disadvantages of the Ross procedure include the creation of a '2-valve' problem as treatment for isolated AoV disease. Nonetheless, the autograft provides unparalleled haemodynamic outcome and durability, resulting in preserved LV function. Reintervention directed at the pulmonary valve either in the interventional catheterization lab or surgical replacement is well tolerated, with low mortality.
For infants, Konno type enlargement of the LVOT is commonly required. The degree of septal incision required for the Ross procedure in which the outflow tract needs to be enlarged only enough to accommodate the pulmonary autograft is much less than that required to accommodate the smallest adult-sized prosthetic valve or even an 'upsized' homograft that is large enough to allow several years of somatic growth. Therefore, the Ross Konno is the preferred operation. Two techniques have been reported. In one, the septal incision and LVOT are enlarged with a prosthetic patch. A second technique involves harvesting a portion of the right ventricular free wall along with the autograft and using this extension to fill in the septal incision and enlarge the LVOT. The drawback of this second technique is the potential for necrosis of the devascularized right ventricular free wall extension with the development of a VSD, which I have encountered.
THE INFECTED AORTIC VALVE
Tom Karl: What are your preferred surgical strategies for infected aortic valves?
Yves d'Udekem
Surgery for endocarditis in the paediatric age requires a simple repair technique using a minimal amount of patch material, which has been shown to provide sustainable long-term results in the adult population [83] . In cases with more extensive valvar destruction, it may be necessary to replace the valve. It has been well established now that even during the active phase of AoV endocarditis, any valve substitute can be used, provided that all infected material is widely resected [84, 85] . The Ross procedure and homografts are still more attractive in this instance because they are permeable to antibiotics [86] . Whenever possible, the Ross procedure is preferred, reserving homografts for situations in which the Ross is perceived to be unfeasible [87] . While homograft longevity varies widely, comparative studies have demonstrated that the average time to replacement is prohibitively short, similarly to what a bioprosthesis could offer [88] . Annular destruction by paravalvar abscess necessitates reconstruction, sometimes extensive, of the fibrous skeleton of the heart [89] [90] [91] . In this circumstance, whether a Ross procedure is combined with the reconstruction depends of the technical confidence of the surgeon facing this challenging procedure. The use of an aortic homograft is then a natural second choice, both because of its resistance to infection and because the presence of the mitralaortic lamina and sometimes the anterior leaflet of the mitral valve, remaining attached to the homograft, may facilitate the reconstruction.
James Tweddell
Native AoV endocarditis may involve only the leaflets, especially in cases of a bicuspid AoV. More extensive cases may involve the aortic annulus, with the development of an aortic root abscess. The initial treatment should include antibiotics directed at the infecting organism. Indications for surgery include heart failure, systemic embolization, large vegetations, uncontrolled infection including development of more invasive infection with aortic annular abscess and conduction system involvement. The duration of antibiotic treatment before surgery influences neither mortality nor the rate of recurrent infective endocarditis. If surgery is indicated, it can proceed as soon as adequate serum levels of antibiotics against the offending organism have been achieved.
If the valve is amenable to simple reconstruction combined with excision of vegetations, then repair is a consideration. Radical repair is no more likely to be successful than in other patients with AI or mixed AS/AI, and valve replacement should be considered. In patients with more extensive infection such as perivalvular abscess, valve repair is unlikely to be successful.
The type of AoV valve prosthesis does not seem to have an impact on the risk of recurrent infection. Although it is a more extensive procedure as an urgent or emergent operation, the Ross procedure has been successfully applied to endocarditis.
Potential advantages of the Ross procedure for endocarditis include the fact that it is living, native tissue and that muscle of the proximal autograft can be used to fill a perivalvular abscess.
CONCLUSION (TOM KARL)
We have been provided an extensive amount of information, based on evidence, opinion and extensive personal experience. Additional related recent EJCTS publications may be of interest [92] [93] [94] [95] [96] [97] [98] . The approaches favoured by our 2 experts are, to my mind, for the most part concordant. Clearly, both discussants have suggested that attention to technical detail and informed preoperative decision-making regarding overall strategy are both critically important for successful short-and long-term outcome. We could speculate that in future discussions of this sort, more extensive use of bioscaffolds and in situ genetic modification of host tissues in AoV reconstructions will be important, along with refinements in non-warfarin-based anticoagulation, and other topics are yet to be revealed. We thank Yves d'Udekem and James Tweddell for sharing their views with the EJCTS community.
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